Concepedia

Karen L. Hadingham

KL

Statistics

Publications

23

Citations

2.2K

H-Index

19

Active since

1992

Affiliations

MSD (UK) Limited (United Kingdom)(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Denver VA Medical Center

University of Colorado Denver

University of Glasgow

Karen L. Hadingham is an author at MSD (UK) Limited (United Kingdom) specializing in neuropharmacology, pharmacology, and neuroscience.

Publications per year

1992–2005

23

Publications

23

Sedation and anesthesia mediated by distinct GABA(A) receptor isoforms.

David S. Reynolds, Thomas W. Rosahl, Jennifer Cirone et al. · PubMed · 2003 · 293 citations · Full text

, , +17

Sedation and Anesthesia Mediated by Distinct GABA<sub>A</sub>Receptor Isoforms

David S. Reynolds, Thomas W. Rosahl, Jennifer Cirone et al. · Journal of Neuroscience · 2003 · 258 citations · Full text

, , +17

Loss of the Major GABA<sub>A</sub>Receptor Subtype in the Brain Is Not Lethal in Mice

Cyrille Sur, Keith A. Wafford, David S. Reynolds et al. · Journal of Neuroscience · 2001 · 232 citations · Full text

, , +17

Genetic knockout and pharmacological blockade studies of the 5-HT7 receptor suggest therapeutic potential in depression

Martin R. Guscott, Linda J. Bristow, Karen L. Hadingham et al. · Neuropharmacology · 2005 · 227 citations

, , +14

Cloning of cDNA sequences encoding human alpha 2 and alpha 3 gamma-aminobutyric acidA receptor subunits and characterization of the benzodiazepine pharmacology of recombinant alpha 1-, alpha 2-, alpha 3-, and alpha 5-containing human gamma-aminobutyric acidA receptors.

Karen L. Hadingham, Peter B. Wingrove, B. Le Bourdellès et al. · Molecular Pharmacology · 1993 · 215 citations · Full text

, , +13

1–5 of 23